Company / Net Income
FATE THERAPEUTICS INC Net Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$186.3M
FY2025
5-year range
-$281.7M / -$98.1M
FY2021-FY2025
Trend
-15.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from -$282M to -$186M over the past 2 years.
Based on SEC 10-K filings.
-$186M in FY2025.
Improved from -$282M to -$186M over the past 2 years.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, net income decreased 15.7% year-over-year.
- Peak net income was recorded in FY2016.
- Lowest net income in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 632.81 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$186.3M | -15.7% |
| FY2024 | -$160.9M | +42.9% |
| FY2023 | -$281.7M | -62.5% |
| FY2022 | -$173.4M | -76.7% |
| FY2021 | -$98.1M | -47.4% |
| FY2020 | -$66.6M | -55.1% |
| FY2019 | -$43.0M | -28.4% |
| FY2018 | -$33.5M | -11.6% |
| FY2017 | -$30.0M | -15.9% |
| FY2016 | -$25.9M | -23.9% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026